Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Feasibility Trial of LHRH Agonist Discontinuation in Elderly Prostate Cancer Patients

NCT06824818 is registered in ClinicalTrials.gov with University of Chicago as lead sponsor.

NCT NCT06824818
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06824818 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Feasibility Trial of LHRH Agonist Discontinuation in Elderly Prostate Cancer Patients
Lead sponsor
University of Chicago
Phase
Not applicable
Overall status
Recruiting
Start date
June 30, 2026
Completion date
June 30, 2027
Enrollment
155 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

elderly, prostate cancer